Rationality and effectiveness of transarterial chemoembolization as an initial treatment for <scp>BCLC</scp> B stage <scp>HBV</scp>‐related hepatocellular carcinoma

Abstract

Transarterial chemoembolization is a safe and efficacious treatment for BCLC B stage HBV-related HCC. A low AFP level, small tumour, low tumour number and good liver function predicted good survival. Tumour response after initial TACE, an independent prognostic factor of overall survival, was associated with tumour extent and influenced subsequent treatment.